CTAG1B and cancer: ImmTAC-NYE (immune-mobilizing monoclonal TCR against cancer) is an anti-NY-ESO-1 × anti-CD3 BsAb, consisting of a TCR-like, anti-HLA-A2/NY-ESO-1157−165 arm fused to an anti-CD3 scFv arm via a peptide linker (89, 215).